← Leaderboards
Elizabeth McCarthy
University Of California, San Francisco
$184,167
Attributed
$184,167
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$184,167 · 1
By mechanism
F30$184,167 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Lawrence Fong$19,816,074
- Hideho Okada$20,052,698
- Susan Halabi$7,630,539
- Kenneth Hadlock$4,184,422
- Manish Aghi$7,964,418
Others in their field
Other Emerging Leaders on “Evolution”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Hensley · University Of Pennsylvania$49,758,212
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- S. Mark Tompkins · University Of Georgia$20,806,329
- Walter Orenstein · Emory University$15,988,348
- Andrew Pekosz · Johns Hopkins University$15,027,681
Research focus
EvolutionEthnic OriginAnti-Ctla4B-Cell ActivationCancer ImmunotherapyAntigen-Presenting CellsCareerAutoimmuneCell CommunicationCell CompartmentationCellsClinical PredictorsCancer TypeClinical Trial ParticipantClonalityCohortCombination ImmunotherapyCombined Modality TherapyComplementary DnaComputing MethodologiesCytometryData SetDendritic Cell VaccineExpression Profiling
Grant awards (4)
Discovery of myeloid immune features predictive of response to cancer immunotherapy in prostate cancer$53,974
F30 · FY2024 · CA · contact PI
Discovery of myeloid immune features predictive of response to cancer immunotherapy in prostate cancer$52,694
F30 · FY2023 · CA · contact PI
Discovery of myeloid immune features predictive of response to cancer immunotherapy in prostate cancer$39,311
F30 · FY2022 · CA · contact PI
Discovery of myeloid immune features predictive of response to cancer immunotherapy in prostate cancer$38,188
F30 · FY2021 · CA · contact PI